Taysha Gene Therapies
TSHA
$2.57
Share price
-0.39%
Change (1 day)
261.97%
Change (1 year)
Taysha Gene Therapies (TSHA) - Total debt
Total debt on the balance sheet as of December 2023 : $61.1 M
According to Taysha Gene Therapies's latest financial reports the company's total debt is $61.1 M. A company’s total debt is the sum of all current and non-current debts.
Taysha Gene Therapies - Total debt on balance sheet (from 2020 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $59.92 M | -5.01% |
| 2021-12-31 | $63.09 M | |
| 2020-12-31 | $N/A |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $2.75 M | -95.50% | 🇺🇸 USA |